0P8.F Penumbra Inc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
289.80 EUR
Close of Nov 12, 2026
234.40 306.40
Market cap
EUR 11.4B
P/E
85.5x
P/B
8.03x
ROE
9.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0P8.F undervalued?

Graham number

The Graham number of Penumbra Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Penumbra Inc fundamental analysis

No fundamental analysis for Penumbra Inc yet.

Penumbra Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide cathete…

Full company profile